The most popular blood biomarker for HCC, alpha-fetoprotein (AFP), demonstrates subpar performance as a serological test in HCC surveillance due to its low sensitivity being only 10%–20% in early-stage HCC and its labile levels during hepatitis flares [8, 9]. This evidence concerns the gene AFP and hepatitis A virus infection.